Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

CELU

CELU News

Newswire

08:51

Celularity and DefEYE Partner to Advance Regenerative Therapies in Eye Care with Exclusive License Agreement and In-Kind Investment.

08:07

Celularity Partners with DefEYE for Ophthalmic Product & Tech Development.

04:47

Nagaland University Researchers Identify Sinapic Acid as Promising Diabetic Wound Treatment

05:07

Unlocking the Secrets of Cell Death: Researchers Explore 'Death Fold' Proteins for Disease Treatment

04:38

Celularity Announces Promising Phase 2 Results for Diabetic Foot Ulcer Treatment, Faces Financial Challenges

View More

About CELU

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More